Charles River Laboratories International (MEX:CRL) Cyclically Adjusted Book per Share: MXN761.57 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CRL Charles River Laboratories International Inc MEX:CRL
51 GF Score
Price MXN4,720.00
GF Value MXN2,782.12
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Charles River Laboratories International Cyclically Adjusted Book per Share?

Charles River Laboratories International MEX:CRL -1.97% 51 Cyclically Adjusted Book per Share is MXN761.57 as of Jun. 2026. GuruFocus rates MEX:CRL with a GF Score™ of 51/100 and a GF Value™ of MXN2,782.12 (Significantly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Charles River Laboratories International's adjusted book value per share for the three months ended in Jun. 2026 was MXN1,038.150. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN761.57 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Charles River Laboratories International's average Cyclically Adjusted Book Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 16.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 18.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Charles River Laboratories International was 21.10% per year. The lowest was -4.30% per year. And the median was 4.20% per year.

As of today (2026-08-16), Charles River Laboratories International's current stock price is MXN4720.00. Charles River Laboratories International's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN761.57. Charles River Laboratories International's Cyclically Adjusted PB Ratio of today is 6.20.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Charles River Laboratories International was 19.58. The lowest was 2.21. And the median was 6.24.


Charles River Laboratories International  (MEX:CRL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Charles River Laboratories International's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4720.00/761.57
=6.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Charles River Laboratories International was 19.58. The lowest was 2.21. And the median was 6.24.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Charles River Laboratories International Cyclically Adjusted Book per Share Related Terms


Charles River Laboratories International Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Cyclically Adjusted Book per Share Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 624.82 614.20 957.25 810.70

Charles River Laboratories International Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,253.61 1,255.74 810.70 973.47 761.57

MEX:CRL vs RVTY, ICLR, QGEN: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted PB Ratio falls into.


MEX:CRL
51GF Score
Charles River Laboratories International Inc MEX:CRL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Charles River Laboratories International's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1038.15/333.9520*333.9520
=1,038.150

Current CPI (Jun. 2026) = 333.9520.

Charles River Laboratories International Quarterly Data

Book Value per Share CPI Adj_Book
201609 354.632 241.428 490.540
201612 364.243 241.432 503.826
201703 346.433 243.801 474.535
201706 365.993 244.955 498.966
201709 391.734 246.819 530.025
201712 432.995 246.524 586.554
201803 432.270 249.554 578.462
201806 483.845 251.989 641.222
201809 487.365 252.439 644.736
201812 536.535 251.233 713.190
201903 556.355 254.202 730.899
201906 572.762 256.143 746.751
201909 619.426 256.759 805.653
201912 629.971 256.974 818.682
202003 782.761 258.115 1,012.745
202006 814.649 257.797 1,055.302
202009 842.555 260.280 1,081.039
202012 845.212 260.474 1,083.641
202103 888.993 264.877 1,120.826
202106 915.855 271.696 1,125.713
202109 988.804 274.310 1,203.795
202112 1,030.097 278.802 1,233.861
202203 1,023.059 287.504 1,188.340
202206 1,047.297 296.311 1,180.337
202209 1,038.567 296.808 1,168.538
202212 1,139.012 296.797 1,281.601
202303 1,094.769 301.836 1,211.255
202306 1,087.404 305.109 1,190.200
202309 1,122.636 307.789 1,218.063
202312 1,189.263 306.746 1,294.741
202403 1,172.907 312.332 1,254.097
202406 1,321.388 314.175 1,404.568
202409 1,456.450 315.301 1,542.603
202412 1,411.628 315.605 1,493.690
202503 1,330.531 319.799 1,389.415
202506 1,283.106 322.561 1,328.418
202509 1,269.333 324.800 1,305.099
202512 1,157.758 324.054 1,193.121
202603 1,100.896 330.213 1,113.361
202606 1,038.150 333.952 1,038.150

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN761.57 mean?
Charles River Laboratories International (MEX:CRL) has a Cyclically Adjusted Book per Share of MXN761.57 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Cyclically Adjusted Book per Share too high?
Charles River Laboratories International's current Cyclically Adjusted Book per Share is MXN761.57. Overall, Charles River Laboratories International has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Cyclically Adjusted Book per Share compare to RVTY and ICLR?
Charles River Laboratories International's Cyclically Adjusted Book per Share of MXN761.57 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Cyclically Adjusted Book per Share is MXN761.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Based on GuruFocus' analysis, Charles River Laboratories International (MEX:CRL) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,782.12, compared to a current price of MXN4,720.00 — trading 69.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is MXN761.57. Charles River Laboratories International's overall GF Score™ is 51/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Charles River Laboratories International (MEX:CRL), the current Cyclically Adjusted Book per Share is MXN761.57 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MEX:CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of MXN4,720.00 is trading 69.7% above its estimated GF Value™ of MXN2,782.12. GuruFocus considers Charles River Laboratories International to be Significantly Overvalued.

Key valuation signals for MEX:CRL:

  • Cyclically Adjusted Book per Share: MXN761.57
  • GF Value™: MXN2,782.12 vs. price of MXN4,720.00 (69.7% above fair value)
  • GF Score™: 51/100 with 9 warning signs

No single metric tells the full story. See the MEX:CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
51GF Score

Get the complete analysis for MEX:CRL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,720.00
Price
MXN2,782.12
GF Value